Operating margin · 2011–2025
Biogen operating margin
15.7%−20.1% · FY2025
Biogen (BIIB) reported 15.7% in operating margin for fiscal 2025, −20.1% year on year.
| Fiscal year | Operating margin | Change | Filing |
|---|---|---|---|
| FY2025 | 15.7% | −20.1% | Derived |
| FY2024 | 19.7% | +49.4% | Derived |
| FY2023 | 13.2% | −49.0% | Derived |
| FY2021 | 25.9% | −23.6% | Derived |
| FY2020 | 33.8% | −30.9% | Derived |
| FY2019 | 49.0% | +11.9% | Derived |
| FY2018 | 43.8% | +0.5% | Derived |
| FY2017 | 43.6% | −3.2% | Derived |
| FY2016 | 45.0% | −1.0% | Derived |
| FY2015 | 45.4% | +11.0% | Derived |
| FY2014 | 40.9% | +12.8% | Derived |
| FY2013 | 36.3% | +7.9% | Derived |
| FY2012 | 33.6% | −1.5% | Derived |
| FY2011 | 34.2% | — | Derived |
Operating margin — Operating margin is operating income divided by revenue. Only companies with at least $1 billion in revenue are ranked here.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth −5.4%
Calculated from two reported figures, so it has no single filing of its own.
Operating margin at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Biogen operating margin |url=https://companiesranked.com/en/company/biogen/operating-margin |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Biogen operating margin. CompaniesRanked. https://companiesranked.com/en/company/biogen/operating-marginBibTeX
@misc{companiesranked-en-company-biogen-operating-margin-2026,
author = {{CompaniesRanked}},
title = {{Biogen operating margin}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/biogen/operating-margin}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.